His primary areas of investigation include Genetics, Ovarian cancer, Breast cancer, Cancer research and Cancer. The various areas that Ian G. Campbell examines in his Ovarian cancer study include Malignant transformation, Endometriosis, Serous fluid, Gene duplication and Tumor suppressor gene. His Breast cancer study necessitates a more in-depth grasp of Internal medicine.
His studies deal with areas such as Methylation, Clear cell, DNA methylation, Carcinogenesis and Loss of heterozygosity as well as Cancer research. His research integrates issues of Exome sequencing, Mutation and Pathology in his study of Cancer. His biological study spans a wide range of topics, including Gene mapping and Genotype.
His scientific interests lie mostly in Ovarian cancer, Breast cancer, Internal medicine, Oncology and Genetics. His research in Ovarian cancer intersects with topics in Cancer research, Serous fluid, Carcinoma, Loss of heterozygosity and Single-nucleotide polymorphism. The study incorporates disciplines such as DNA methylation, Carcinogenesis, Tumor suppressor gene, Mutation and Ovarian carcinoma in addition to Cancer research.
The Breast cancer study combines topics in areas such as Germline mutation, Allele and Pathology. Ian G. Campbell has researched Oncology in several fields, including Genetic predisposition, Genetic testing, Gene mutation, PALB2 and Cohort. His Genome-wide association study study combines topics from a wide range of disciplines, such as Genotyping, Genetic association and Bioinformatics.
His main research concerns Internal medicine, Oncology, Breast cancer, Ovarian cancer and Cancer research. Ian G. Campbell has included themes like Germline, Single-nucleotide polymorphism, Family history, Cohort and Candidate gene in his Oncology study. Cancer covers Ian G. Campbell research in Breast cancer.
His work deals with themes such as Genome-wide association study, Disease and Gene, which intersect with Ovarian cancer. His Genome-wide association study study incorporates themes from Genetic correlation, Cancer Etiology, Locus, Lung cancer and Scaffold/matrix attachment region. His study in Cancer research is interdisciplinary in nature, drawing from both Copy number analysis and Carcinoma.
Ian G. Campbell mostly deals with Breast cancer, Internal medicine, Oncology, Cancer research and Ovarian cancer. Breast cancer is a subfield of Cancer that Ian G. Campbell studies. His work is dedicated to discovering how Internal medicine, Germline mutation are connected with Genetic predisposition, Mutation, Exome, Gene dosage and Chromosome 22 and other disciplines.
His Oncology research is multidisciplinary, incorporating elements of Retrospective cohort study, Hazard ratio, Single-nucleotide polymorphism, Genetic testing and Index case. His Cancer research study integrates concerns from other disciplines, such as Copy number analysis, Carcinoma, Gene and Adenocarcinoma. His Ovarian cancer research includes elements of Family history, Genetic counseling, Family Cancer History, Survival analysis and Etiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutation of the PIK3CA gene in ovarian and breast cancer.
Ian G. Campbell;Sarah E. Russell;David Y. H. Choong;Karen G. Montgomery.
Cancer Research (2004)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Co-evolution of tumor cells and their microenvironment.
Kornelia Polyak;Izhak Haviv;Ian G. Campbell;Ian G. Campbell.
Trends in Genetics (2009)
The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.
Amanda J. Philp;Ian G. Campbell;Christine Leet;Elizabeth Vincan.
Cancer Research (2001)
Folate-binding Protein Is a Marker for Ovarian Cancer
Ian G. Campbell;Tania A. Jones;William D. Foulkes;John Trowsdale.
Cancer Research (1991)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
Koshiro Obata;Sarah J. Morland;Richard H. Watson;Andrew Hitchcock.
Cancer Research (1998)
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan.
Nature Genetics (2013)
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
P. Garin-Chesa;I. Campbell;P. E. Saigo;J. L. Lewis.
American Journal of Pathology (1993)
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Ellen L Goode;Georgia Chenevix-Trench;Honglin Song;Susan J Ramus.
Nature Genetics (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of New South Wales
University of Melbourne
German Cancer Research Center
QIMR Berghofer Medical Research Institute
Monash University
University of Southampton
University of Cambridge
University of California, Los Angeles
Pomeranian Medical University
Cedars-Sinai Medical Center
University of British Columbia
Meijo University
Institut de Physique du Globe de Paris
Otto-von-Guericke University Magdeburg
National Institute for Materials Science
Brigham and Women's Hospital
Monash University
Kyushu University
University of Wisconsin–Madison
Catholic University of the Sacred Heart
University of Debrecen
University of Manchester
University of Oxford
National Institutes of Health
University of New Mexico
Memorial Sloan Kettering Cancer Center